Clearside Biomedical, Inc. - Common Stock (CLSD)

Clearside Biomedical is a biopharmaceutical company focused on developing innovative therapies for eye diseases

The company specializes in the delivery of drugs to the back of the eye, utilizing its proprietary suprachoroidal injection platform to enhance treatment efficacy and minimize side effects. Clearside’s pipeline includes formulations targeting conditions such as wet age-related macular degeneration and other retinal disorders, with the aim of providing improved therapeutic options for patients suffering from these debilitating conditions. Through its advancements in ocular drug delivery, Clearside seeks to transform the treatment landscape for various eye diseases.